Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results
Date:11/8/2010

7 and 259,884 weighted average diluted shares outstanding for the three months ended September 25, 2010 and September 26, 2009, respectively.(3) To reflect an estimated annual effective tax rate of 36.2% on a non-GAAP basis.(4) To reflect an estimated annual effective tax rate of 35% on a non-GAAP basis.HOLOGIC, INC.RECONCILIATION OF GAAP EPS AND NET LOSS TO NON-GAAP ADJUSTED EPS, NET INCOME AND EBITDA(Unaudited)(In thousands, except earnings per share)Twelve Months Ended
September 25, 2010Twelve Months Ended
September 26, 2009 (1)(LOSS) EARNINGS PER SHAREGAAP loss per share- Diluted

$
(0.24)$
(8.64)

(1)Adjustments to net loss (as detailed below)

1.429.81Non-GAAP adjusted earnings per share- Diluted

$
.18

(2)$
.17

(2)NET (LOSS) INCOMEGAAP net loss

$
(62,813)$
(2,216,642)

(1)Adjustments:Amortization of  intangible assets  

226,305206,729Non-cash interest expense relating to convertible debt

73,13067,673Impairment of goodwill

76,7232,340,023Impairment of intangible assets

143,4674,065Litigation settlement charges, net

11,403-Acquisition-related costs

2,226-Acquired in-process research and development

2,000-Divestiture, closing and restructuring costs

1,5812,002Fair value write-up of acquired inventory sold

7321,167Income tax effect of reconciling items

(166,774)

(3)(101,123)

(4)Non-GAAP adjusted net income

$
307,980$
303,894EBITDANon-GAAP adjusted net income

$
307,980$
303,894Interest expense, net, not adjusted above

52,69966,123Provision for income taxes

174,596163,635Depreciation expense

68,46367,195Adjusted EBITDA

$
3,738$
,847EXPLANATORY NOTES:(1) Adjusted for the retrospective adoption of ASC 470-20, "Accounting for Convertible Debt Instruments That May be Settled in Cash Upo
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study
2. Hologic to Host Investor Presentation at RSNA 2010
3. Hologic to Release Fourth Quarter Fiscal 2010 Operating Results on Monday, November 8, 2010
4. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
5. Hologic to Present at the 2010 Morgan Stanley Global Healthcare Conference
6. Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
7. Hologic Announces Decision in Patent Infringement Suit
8. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
9. New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity
10. Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009
11. Hologic to Present at NASDAQ OMX 23rd Investor Program in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... Confirms Role of AMBIEN CR in Effectively Managing Insomnia to ... Improve Quantity and Quality of Work Performance, BRIDGEWATER, ... study that showed patients with chronic,insomnia who were treated with ... experienced significant improvements in two,key parameters of work performance - ...
... - favorable pharmacokinetic and safety data observed in first ... trial of novel Fleximer(TM) anticancer ... a cancer,therapeutics company, announced interim results of a Phase ... with advanced solid tumors.,The data was presented by Edward ...
Cached Medicine Technology:New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 4Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 2Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 3
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... heart failure rarely occurs among leukemia patients who take ... Anderson Cancer Center found after an exhaustive review of ... in clinical trials for the drug. , Researchers found ... have been caused by heart failure. Of those, 18 ...
... edition of The Journal of Immunology provide key new ... a principal investigator in SBRIs Viral Vaccines Program who ... Medical Center, is senior author on one of three ... symptom of AIDS, is likely a part of a ...
... Universal,Health Realty Income Trust (NYSE: UHT ) ... pay a quarterly dividend of $.575 per share ... of September 17, 2007. Universal Health Realty ... healthcare and human service related facilities including acute,care ...
... 6 ABQAURP is pleased to announce the,2007-08 ... Medical,Errors." The core content includes patient safety initiatives, ... populations,responsibility for error reporting and public education. ... -- serious and,costly errors in the provision of ...
... An Evening with Tim McGraw and Friends, ... Presented by Anheuser-Busch Companies, NAPA, Calif., ... annual fundraising gala on Friday, Nov. 2 at Grant,s Farm,the ... Anheuser-Busch,Companies is sponsoring "Denim & Diamonds: An Evening with Tim ...
... - MaxLife Fund Corp. (OTC:,MXFD), is pleased to announce ... Settlement Policies with a total face value of $4,000,000. ... Settlement,Policies and Portfolios that are available to be purchased. ... the company to profit,and create value for our shareholders. ...
Cached Medicine News:Health News:Study finds heart failure is rare among leukemia patients on imatinib 2Health News:Study finds heart failure is rare among leukemia patients on imatinib 3Health News:SIV infection of natural hosts provides new insights into HIV disease complexity 2Health News:ABQAURP Announces Certificate Course in Medical Error Prevention 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 4
...
...
...
... Anterior Cervical Plate System allows for ... along slots in the plate, while ... end of the construct. In addition, ... pre-compression features that enable the surgeon ...
Medicine Products: